NCT02265068View on ClinicalTrials.gov

Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes

CompletedOBSERVATIONAL
Enrollment

700

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Acute Coronary Syndrome (ACS)
Interventions
DRUG

Ticagrelor

Treatment of ACS patients with Ticagrelor

Trial Locations (6)

12351

Vivantes-Klinikum Neukölln, Berlin

31135

Klinikum Hildesheim GmbH, Hildesheim

35578

Klinikum-Wetzlar Braunsfeld, Wetzlar

84036

Krankenhaus Landshut-Achdorf, Landshut

99437

Zentralklinik Bad Berka GmbH, Bad Berka

Unknown

Klinikum Ludwigshafen, Ludwigshafen

All Listed Sponsors
lead

IHF GmbH - Institut für Herzinfarktforschung

OTHER

NCT02265068 - Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes | Biotech Hunter | Biotech Hunter